Castleview Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-537
Closed -$8.81K 578
2024
Q2
$8.81K Buy
+537
New +$8.63K 0.01% 547

Other funds holding BCAT

Castleview Partners's BCAT Position: Q3 2024 in Review

Castleview Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2024, closing a stake of 537 shares — an estimated $8.81K sold.

Castleview Partners first reported a position in BCAT in Q2 2024 and held it in 1 quarter. The position peaked at $8.81K in Q2 2024. 80 funds tracked by Wall St. Rank hold BCAT as of Q3 2024.

  • Castleview Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 537 BlackRock Capital Allocation Term Trust shares in Q3 2024, an estimated $8.81K.
  • Castleview Partners first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and held it in 1 quarter.
  • Castleview Partners's BlackRock Capital Allocation Term Trust position peaked at $8.81K in Q2 2024.
  • 80 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.